Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,570 across all filing types
Latest filing 2022-12-09 Legal Proceedings Report
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
汉商集团关于参与重庆东方药业股份有限公司破产重整进展的公告
Legal Proceedings Report Classification · 95% confidence The document is an announcement by 汉商集团股份有限公司 regarding the progress of its participation in the bankruptcy reorganization of 重庆东方药业股份有限公司. It includes details about a court ruling approving the reorganization plan and the termination of the reorganization procedure, as well as the company's plans for subsequent steps and risk warnings. The document is relatively short (991 characters) and serves as a formal update on a legal and financial matter related to restructuring. It does not contain financial statements, detailed financial analysis, or comprehensive report content. It is not a full annual or interim report, nor an earnings release or audit report. It is also not a proxy, voting result, or management change announcement. Given the nature of the content—legal and restructuring progress update—the best fitting category is Legal Proceedings Report (LTR).
2022-12-09 Chinese
汉商集团关于2022年第三季度业绩说明会召开情况的公告
Call Transcript Classification · 95% confidence The document is titled as an announcement regarding the 2022 third quarter earnings explanation meeting of 汉商集团股份有限公司. It details the occurrence of the earnings explanation meeting, the attendance of company executives, and a Q&A session with investors covering various business topics including restructuring, product competitiveness, acquisitions, and future plans. The document is a detailed narrative of the earnings call or earnings explanation meeting rather than a brief earnings release or a full quarterly report with financial statements. It does not contain actual financial statements or comprehensive financial data but rather a discussion and Q&A format. This matches the characteristics of a Call Transcript (CT) rather than an Earnings Release (ER) or Interim Report (IR). The length (6731 characters) and content support this classification. Therefore, the document is best classified as a Call Transcript (CT).
2022-12-08 Chinese
汉商集团关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from 汉商集团股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total funds used, and references the board meeting approving the repurchase plan. The document is relatively short (1272 characters) and focuses on the company's buyback activity rather than presenting financial statements or comprehensive financial data. It does not contain quarterly or annual financial results, nor is it a report or presentation. The content aligns with a Transaction in Own Shares (POS) filing, which reports on share repurchase activities.
2022-11-30 Chinese
汉商集团关于召开2022年第三季度业绩说明会的公告
Investor Presentation Classification · 90% confidence The document is an announcement about the scheduling and details of a 2022 third quarter earnings explanation meeting (业绩说明会). It provides information on the meeting time, location, format, participants, and how investors can participate and ask questions. It references the previously released 2022 third quarter report but does not contain any financial data or results itself. The document is short (1406 characters) and serves to inform investors about the upcoming earnings call rather than presenting the earnings results or detailed financial statements. Therefore, it is best classified as a Call Transcript announcement or related to the earnings call event. However, since it is an announcement of the earnings explanation meeting rather than the transcript or the earnings release itself, the closest fitting category is Investor Presentation (IP), which covers detailed presentations for investors focusing on financials, strategy, and market position, including earnings explanation meetings. Confidence is high given the clear description of the meeting and its purpose.
2022-11-28 Chinese
汉商集团关于参与重庆东方药业股份有限公司破产重整进展的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the progress of the company's participation in the bankruptcy reorganization of another company, Chongqing Dongfang Pharmaceutical Co., Ltd. It details the approval of the reorganization plan by creditors, the subsequent legal steps, and the potential impact and risks to the company. The document is a formal public announcement about a corporate restructuring event and does not contain financial statements, audit information, or detailed financial results. It is not a full annual or interim report, nor is it a call transcript or management report. It is also not a merger or acquisition filing but rather an update on a bankruptcy reorganization progress. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-11-10 Chinese
汉商集团关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from 汉商集团股份有限公司 regarding the progress of its share repurchase program. It details the number of shares repurchased, the price range, total funds used, and references the board meeting approving the repurchase plan. The document also cites regulatory compliance and ongoing disclosure obligations. The content focuses exclusively on the company's buyback of its own shares and does not contain financial statements or broader financial results. The document length is short (1272 characters), and it is a direct announcement of share repurchase activity rather than a report or presentation. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2022-10-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.